When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRK - Aptose Shoots Up As Investors Focus On Reversible BTK Inhibitors
Merck & Company Inc.
I’ve written before that I consider Aptose Biosciences (APTO) to be a “speculation worth considering” on the strength of its two-drug pipeline for hematology, and between Merck’s (MRK) $2.7 billion bid for ArQule (ARQL) and encouraging early-stage data for the second-gen BTK inhibitor class at this past weekend’s ASH meeting, Aptose shares are having a great Monday – up about 30% as of this writing.
Is Monday’s move fair? As far as a one-day move after the ASH meeting and Merck’s bid, I would say it is probably